240 related articles for article (PubMed ID: 33078654)
1.
Lee DH; Park SH; Ahn J; Hong SP; Lee E; Jang YJ; Ha TY; Huh YH; Ha SY; Jeon TI; Jung CH
Autophagy; 2021 Sep; 17(9):2415-2431. PubMed ID: 33078654
[TBL] [Abstract][Full Text] [Related]
2. Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease.
Ren Q; Sun Q; Fu J
Autophagy; 2024 Feb; 20(2):221-241. PubMed ID: 37700498
[TBL] [Abstract][Full Text] [Related]
3. Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.
Zou Z; Liu X; Yu J; Ban T; Zhang Z; Wang P; Huang R; Zheng F; Chang Y; Peng W; Tang Y; Feng X; Zhao Z; Lv X; Huang S; Guo J; Tuo Y; Zhou Z; Liang S
J Hepatol; 2024 Jun; 80(6):834-845. PubMed ID: 38331323
[TBL] [Abstract][Full Text] [Related]
4. Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy.
Song Y; Yang H; Kim J; Lee Y; Kim SH; Do IG; Park CY
Mol Metab; 2023 Dec; 78():101806. PubMed ID: 37739179
[TBL] [Abstract][Full Text] [Related]
5. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
[TBL] [Abstract][Full Text] [Related]
6. Poliovirus induces autophagic signaling independent of the ULK1 complex.
Corona Velazquez A; Corona AK; Klein KA; Jackson WT
Autophagy; 2018; 14(7):1201-1213. PubMed ID: 29929428
[TBL] [Abstract][Full Text] [Related]
7. Role of CircCHD2 in the pathogenesis of gestational diabetes mellitus by regulating autophagy via miR-33b-3p/ULK1 axis.
Bao Y; Wu L; Liu Y; Fan C; Zhang J; Yang J
Placenta; 2024 Jan; 145():27-37. PubMed ID: 38039841
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPK
Yu Y; He C; Tan S; Huang M; Guo Y; Li M; Zhang Q
Anal Cell Pathol (Amst); 2021; 2021():4853355. PubMed ID: 35004133
[TBL] [Abstract][Full Text] [Related]
9. MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1.
Ding J; Xia C; Cen P; Li S; Yu L; Zhu J; Jin J
Mol Biol Rep; 2022 Aug; 49(8):7297-7305. PubMed ID: 35606603
[TBL] [Abstract][Full Text] [Related]
10. Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation.
Schwerbel K; Kamitz A; Krahmer N; Hallahan N; Jähnert M; Gottmann P; Lebek S; Schallschmidt T; Arends D; Schumacher F; Kleuser B; Haltenhof T; Heyd F; Gancheva S; Broman KW; Roden M; Joost HG; Chadt A; Al-Hasani H; Vogel H; Jonas W; Schürmann A
J Hepatol; 2020 Oct; 73(4):771-782. PubMed ID: 32376415
[TBL] [Abstract][Full Text] [Related]
11. Loss of miR-144/451 alleviates β-thalassemia by stimulating ULK1-mediated autophagy of free α-globin.
Keith J; Christakopoulos GE; Fernandez AG; Yao Y; Zhang J; Mayberry K; Telange R; Sweileh RBA; Dudley M; Westbrook C; Sheppard H; Weiss MJ; Lechauve C
Blood; 2023 Sep; 142(10):918-932. PubMed ID: 37339583
[TBL] [Abstract][Full Text] [Related]
12. RORα Enhances Lysosomal Acidification and Autophagic Flux in the Hepatocytes.
Kim HJ; Han YH; Kim JY; Lee MO
Hepatol Commun; 2021 Dec; 5(12):2121-2138. PubMed ID: 34558854
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling.
Lin C; Blessing AM; Pulliam TL; Shi Y; Wilkenfeld SR; Han JJ; Murray MM; Pham AH; Duong K; Brun SN; Shaw RJ; Ittmann MM; Frigo DE
Oncogene; 2021 Mar; 40(9):1690-1705. PubMed ID: 33531625
[TBL] [Abstract][Full Text] [Related]
14. Exercise ameliorates lipid droplet metabolism disorder by the PLIN2-LIPA axis-mediated lipophagy in mouse model of non-alcoholic fatty liver disease.
Fang C; Liu S; Yang W; Zheng G; Zhou F; Gao X; Qin L; Yang G; Yang J; Zhu G; Wang X; Huang K; Yang X; Wei Y; Peng S; Li L
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167045. PubMed ID: 38306800
[TBL] [Abstract][Full Text] [Related]
15. AMPK/mTOR pathway significance in healthy liver and non-alcoholic fatty liver disease and its progression.
Marcondes-de-Castro IA; Reis-Barbosa PH; Marinho TS; Aguila MB; Mandarim-de-Lacerda CA
J Gastroenterol Hepatol; 2023 Nov; 38(11):1868-1876. PubMed ID: 37438882
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MIR22HG/microRNA-9-3p/IGF1 in nonalcoholic steatohepatitis, the ceRNA network increases fibrosis by inhibiting autophagy and promoting pyroptosis.
Chen X; Zhou S; Chen Y; Tong K; Huang W
Clin Nutr; 2024 Jan; 43(1):52-64. PubMed ID: 38011754
[TBL] [Abstract][Full Text] [Related]
17. Methylsulfonylmethane ameliorates metabolic-associated fatty liver disease by restoring autophagy flux via AMPK/mTOR/ULK1 signaling pathway.
Han D; Kim D; Kim H; Lee J; Lyu J; Kim JS; Shin J; Kim JS; Kim DK; Park HW
Front Pharmacol; 2023; 14():1302227. PubMed ID: 38099147
[No Abstract] [Full Text] [Related]
18. MicroRNA-665-3p exacerbates nonalcoholic fatty liver disease in mice.
Yu Y; Tian T; Tan S; Wu P; Guo Y; Li M; Huang M
Bioengineered; 2022 Feb; 13(2):2927-2942. PubMed ID: 35038955
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice.
Lin CW; Zhang H; Li M; Xiong X; Chen X; Chen X; Dong XC; Yin XM
J Hepatol; 2013 May; 58(5):993-9. PubMed ID: 23339953
[TBL] [Abstract][Full Text] [Related]
20. CREBH promotes autophagy to ameliorate NASH by regulating Coro1a.
Deng X; Liu B; Jiang Q; Li G; Li J; Xu K
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166914. PubMed ID: 37837948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
